Marlene Jan Mekel

Title: Marlene Jan Mekel: Innovator in Prolyl Hydroxylase Research

Introduction

Marlene Jan Mekel is a distinguished inventor based in Ross, Ohio, known for her significant contributions to the field of biochemistry. With a total of three patents to her name, she has made remarkable strides in understanding and manipulating prolyl hydroxylase, a key enzyme involved in cellular responses to oxygen levels.

Latest Patents

Mekel's latest patents include the innovative "Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase." This patent discloses the crystal structure of the ligand-bound EGLN1 catalytic domain of prolyl hydroxylase. The coordinates provided in this patent are instrumental in computer-aided drug design, aiding in the identification of compounds that can regulate EGLN1 prolyl hydroxylase and, consequently, HIF-regulated disorders.

Career Highlights

Throughout her career, Marlene has worked with prominent companies such as The Procter & Gamble Company and Warner Chilcott Company, LLC. Her experience in these organizations has allowed her to apply her research in practical settings, contributing to advancements in health and medicine.

Collaborations

Mekel has collaborated with notable professionals in her field, including Artem G Evdokimov and Richard Masaru Kawamoto. These partnerships have further enriched her research and innovation efforts.

Conclusion

Marlene Jan Mekel stands out as a pioneering inventor in the realm of prolyl hydroxylase research. Her patents and collaborations reflect her commitment to advancing scientific knowledge and improving health outcomes.